Epidemiology

You have full text access to this OnlineOpen article

Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma†

  1. Sara Gandini1,
  2. Mathieu Boniol2,
  3. Jari Haukka3,
  4. Graham Byrnes4,
  5. Brian Cox5,
  6. Mary Jane Sneyd5,
  7. Patrick Mullie6,
  8. Philippe Autier2,*

Article first published online: 6 MAY 2010

DOI: 10.1002/ijc.25439

Issue

International Journal of Cancer

International Journal of Cancer

Volume 128, Issue 6, pages 1414–1424, 15 March 2011

Additional Information

How to Cite

Gandini, S., Boniol, M., Haukka, J., Byrnes, G., Cox, B., Sneyd, M. J., Mullie, P. and Autier, P. (2011), Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int. J. Cancer, 128: 1414–1424. doi: 10.1002/ijc.25439

Author Information

  1. 1

    European Institute of Oncology, Milano, Italy

  2. 2

    International Prevention Research Institute (IPRI), Lyon, France

  3. 3

    Department of Public Health, Faculty of Medicine, University of Helsinki, Finland

  4. 4

    International Agency for Research on Cancer, Lyon, France

  5. 5

    Hugh Adam Cancer Epidemiology Unit, Dunedin School of Medicine, University of Otago, New Zealand

  6. 6

    Department of Nutrition, Preventive Medicine and Leuven Food Science and Nutrition Research Centre (LFoRCe), Catholic University Leuven, Leuven, Belgium

*International Prevention Research Institute (IPRI), 95 Cours Lafayette, Lyon 69006, France

  1. †

    Conflict of Interest: Jari Haukka reported research collaborations with the companies Janssen-Cilag, Eli Lilly, and Astellas. Other authors had no conflict of interest to declare.

Publication History

  1. Issue published online: 28 JAN 2011
  2. Article first published online: 6 MAY 2010
  3. Manuscript Accepted: 16 APR 2010
  4. Manuscript Received: 7 JAN 2010

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (331K)

References

  • 1
    Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. J Physiol Renal Physiol 2005; 289: 8–28.
  • 2
    Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 2005; 16: 83–9.
  • 3
    Tjellesen L, Christiansen C. Vitamin D metabolites in normal subjects during one year. A longitudinal study. Scand J Clin Lab Invest 1983; 43: 85–9.
  • 4
    Hine TJ, Roberts NB. Seasonal variation in serum 25-hydroxy vitamin D3 does not affect 1,25-dihydroxy vitamin D. Ann Clin Biochem 1994; 31( part 1): 31–4.
  • 5
    Garland CF, Comstock GW, Garland FC, Helsing KJ, Shaw EK, Gorham ED. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 1989; 2: 1176–8.
  • 6
    Greenland S. Variance estimators for attributable fraction estimates consistent in both large strata and sparse data. Stat Med 1987; 6: 701–8.
    Direct Link:
  • 7
    Jenab M, Bueno-de-Mesquita JB, Ferrari P, van Duijnhoven FJB, Norat T, Pischon T, Jansen EHJM, Slimani N, Byrnes G, Rinaldi S, Tjønneland A, Olsen A, et al. Pre-diagnostic circulating vitamin D concentration, dietary vitamin D and calcium and risk of colorectal cancer in european populations. BMJ 2010; 340: b5500.
  • 8
    Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539–58.
    Direct Link:
  • 9
    Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 1992; 135: 1301–9.
  • 10
    van Houwelingen HC, Arends LR, Stijnen T. Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med 2002; 21: 589–624.
    Direct Link:
  • 11
    Colditz GA, Burdick E, Mosteller F. Heterogeneity in meta-analysis of data from epidemiologic studies: a commentary. Am J Epidemiol 1995; 142: 371–82.
  • 12
    Macaskill P, Walter SD, Irwig L. A comparison of methods to detect publication bias in meta-analysis. Stat Med 2001; 20: 641–54.
    Direct Link:
  • 13
    Braun MM, Helzlsouer KJ, Hollis BW, Comstock GW. Colon cancer and serum vitamin D metabolite levels 10-17 years prior to diagnosis. Am J Epidemiol 1995; 142: 608–11.
  • 14
    Tangrea J, Helzlsouer K, Pietinen P, Taylor P, Hollis B, Virtamo J, Albanes D. Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control 1997; 8: 615–25.
  • 15
    Yaylim-Eraltan I, Arzu Ergen H, Arikan S, Okay E, Ozturk O, Bayrak S, Isbir T. Investigation of the VDR gene polymorphisms association with susceptibility to colorectal cancer. Cell Biochem Funct 2007; 25: 731–7.
    Direct Link:
  • 16
    Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, O'Sullivan MJ, Margolis KL, Ockene JK, Phillips L, Pottern L, Prentice RL, Robbins J, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006; 354: 684–96.
  • 17
    Freedman DM, Looker AC, Chang SC, Graubard BI. Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst 2007; 99: 1594–602.
  • 18
    Otani T, Iwasaki M, Sasazuki S, Inoue M, Tsugane S. Plasma vitamin D and risk of colorectal cancer: the Japan Public Health Center-Based Prospective Study. Br J Cancer 2007; 97: 446–51.
  • 19
    Wu K, Feskanich D, Fuchs CS, Willett WC, Hollis BW, Giovannucci EL. A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J Natl Cancer Inst 2007; 99: 1120–9.
  • 20
    Bertone-Johnson ER, Chen WY, Holick MF, Hollis BW, Colditz GA, Willett WC, Hankinson SE. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 1991–7.
  • 21
    Colston KW, Lowe LC, Mansi JL, Campbell MJ. Vitamin D status and breast cancer risk. Anticancer Res 2006; 26: 2573–80.
  • 22
    Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, Chang-Claude J. Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer–results of a large case-control study. Carcinogenesis 2008; 29: 93–9.
  • 23
    Abbas S, Chang-Cluade J, Linseisen J. Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study. Int J Cancer 2009; 124: 250–5.
    Direct Link:
  • 24
    Freedman DM, Chang SC, Falk RT, Purdue MP, Huang WY, McCarty CA, Hollis BW, Graubard BI, Berg CD, Ziegler RG. Serum levels of vitamin D metabolites and breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev 2008; 17: 889–94.
  • 25
    Chlebowski RT, Johnson KC, Kooperberg C, Pettinger M, Wactawski-Wende J, Rohan T, Rossouw J, Lane D, O'Sullivan MJ, Yasmeen S, Hiatt RA, Shikany JM, et al. Calcium plus vitamin d supplementation and the risk of breast cancer. J Natl Cancer Inst 2007; 100: 1581–91.
  • 26
    Crew KD, Gammon MD, Steck SE, Hershman DL, Cremers S, Dworakowski E, Shane E, Terry MB, Desai M, Teitelbaum SL, Neugut AI, Regina M, et al. Association between plasma 25-hydroxyvitamin D and breast cancer risk. Cancer Prev Res 2009; 2: 598–604.
  • 27
    McCullough ML, Robertson AS, Rodriguez C, Jacobs EJ, Chao A, Carolyn J, Calle EE, Willett WC, Thun MJ. Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition Cohort. Breast Cancer Res 2009; 11: R64.
  • 28
    Rejnmark L, Tietze A, Vestergaard P, Buhl L, Lehbrink M, Heickendorff L, Mosekilde L. Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev 2009; 18: 2655–60.
  • 29
    Braun MM, Helzlsouer KJ, Hollis BW, Comstock GW. Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States). Cancer Causes Control 1995; 6: 235–9.
  • 30
    Nomura AM, Stemmermann GN, Lee J, Kolonel LN, Chen TC, Turner A, Holick MF. Serum vitamin D metabolite levels and the subsequent development of prostate cancer (Hawaii, United States). Cancer Causes Control 1998; 9: 425–32.
  • 31
    Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P. Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control 2000; 11: 847–52.
  • 32
    Jacobs ET, Giuliano AR, Martinez ME, Hollis BW, Reid ME, Marshall JR. Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer. J Steroid Biochem Mol Biol 2004; 89–90: 533–7.
  • 33
    Baron JA, Beach M, Wallace K, Grau MV, Sandler RS, Mandel JS, Heber D, Greenberg ER. Risk of prostate cancer in a randomized clinical trial of calcium supplementation. Cancer Epidemiol Biomarkers Prev 2005; 14: 586–9.
  • 34
    Faupel-Badger JM, Diaw L, Albanes D, Virtamo J, Woodson K, Tangrea JA. Lack of association between serum levels of 25-hydroxyvitamin d and the subsequent risk of prostate cancer in Finnish men. Cancer Epidemiol Biomarkers Prev 2007; 16: 2784–6.
  • 35
    Li H, Stampfer MJ, Hollis JB, Mucci LA, Gaziano JM, Hunter D, Giovannucci EL, Ma J A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer. PLoS Med 2007; 4: e103.
  • 36
    Mikhak B, Hunter DJ, Spiegelman D, Platz EA, Hollis BW, Giovannucci E. Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and prostate cancer risk. Prostate 2007; 67: 911–23.
    Direct Link:
  • 37
    Ahn J, Peters U, Albanes D, Purdue MP, Abnet CC, Chatterjee N, Horst RL, Hollis BW, Huang WY, Shikany JM, Hayes RB. Serum vitamin D concentration and prostate cancer risk: a nested case-control study. J Natl Cancer Inst 2008; 100: 796–804.
  • 38
    Travis RC, Crowe FL, Allen NE, Appleby PN, Roddam AW, Tjønneland A, Olsen A, Linseisen J, Kaaks R, Boeing H, Kröger J, Sacerdote C, et al. Serum vitamin D and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition. Am J Epidemiol 2009; 169: 1223–32.
  • 39
    Platz EA, Hankinson SE, Hollis BW, Colditz GA, Hunter DJ, Speizer FE, Giovannucci E. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum. Cancer Epidemiol Biomarkers Prev 2000; 9: 1059–65.
  • 40
    Levine AJ, Harper JM, Ervin CM, Chen YH, Harmon E, Xue S, Lee ER, Frankel HD, Haile RW. Serum 25-hydroxyvitamin D, dietary calcium intake, and distal colorectal adenoma risk. Nutr Cancer 2001; 39: 35–41.
  • 41
    Peters U, McGlynn KA, Chatterjee N, Gunter E, Garcia-Closas M, Rothman N, Sinha R. Vitamin D, calcium, and vitamin D receptor polymorphism in colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2001; 10: 1267–74.
  • 42
    Grau MV, Baron JA, Sandler RS, Haile RW, Beach ML, Church TR, Heber D. Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst 2003; 95: 1765–71.
  • 43
    Peters U, Hayes RB, Chatterjee N, Shao W, Schoen RE, Pinsky P, Hollis BW, McGlynn KA. Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2004; 13: 546–52.
  • 44
    Jacobs ET, Alberts DS, Benuzillo J, Hollis BW, Thompson PA, Martinez ME. Serum 25(OH)D levels, dietary intake of vitamin D, and colorectal adenoma recurrence. J Steroid Biochem Mol Biol 2007; 103: 752–6.
  • 45
    Miller EA, Keku TO, Satia JA, Martin CF, Galanko JA, Sandler RS. Calcium, dietary, and lifestyle factors in the prevention of colorectal adenomas. Cancer 2007; 109: 510–17.
    Direct Link:
  • 46
    Niv Y, Sperber AD, Figer A, Igael D, Shany S, Fraser G, Schwartz B. In colorectal carcinoma patients, serum vitamin D levels vary according to stage of the carcinoma. Cancer 1999; 86: 391–7.
    Direct Link:
  • 47
    Sieg J, Sieg A, Dreyhaupt J, Schmidt-Gayk H. Insufficient vitamin D supply as a possible co-factor in colorectal carcinogenesis. Anticancer Res 2006; 26: 2729–33.
  • 48
    Feskanich D, Ma J, Fuchs CS, Kirkner GJ, Hankinson SE, Hollis BW, Giovannucci EL. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 2004; 13: 1502–8.
  • 49
    Lowe LC, Guy M, Mansi JL, Peckitt C, Bliss J, Wilson RG, Colston KW. Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer 2005; 41: 1164–9.
  • 50
    Gann PH, Ma J, Hennekens CH, Hollis BW, Haddad JG, Stampfer MJ. Circulating vitamin D metabolites in relation to subsequent development of prostate cancer. Cancer Epidemiol Biomarkers Prev 1996; 5: 121–6.
  • 51
    Platz EA, Rimm EB, Willett WC, Kantoff PW, Giovannucci E. Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals. J Natl Cancer Inst 2000; 92: 2009–17.
  • 52
    Platz EA, Leitzmann MF, Hollis BW, Willett WC, Giovannucci E. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Causes Control 2004; 15: 255–65.
  • 53
    Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, Hallmans G, Stattin P, Harvei S, Hakulinen T, Luostarinen T, Dillner J, Lehtinen M, et al. Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int J Cancer 2004; 108: 104–8.
    Direct Link:
  • 54
    Comstock GW, Helzlsouer KJ, Bush TL. Prediagnostic serum levels of carotenoids and vitamin E as related to subsequent cancer in Washington County, Maryland. Am J Clin Nutr 1991; 53( Suppl.): 260S–264S.
  • 55
    Lieberman DA, Prindiville S, Weiss DG, PhD, Willett WC. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA 2003; 290: 2959–7.
  • 56
    Lips P, Chapuy MC, Hughes BD, Pols HA, Holick MF. An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporos Int 1999; 9: 394–7.
  • 57
    Hypponen E, Power C. Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 2007; 85: 860–8.
  • 58
    Wei MY, Garland CF, Gorham ED, Mohr SB, Giovannucci E. Vitamin D and prevention of colorectal adenoma: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2008; 17: 2958–69.
  • 59
    Chen P, Hu P, Xie D, Qin Y, Wang F, Wang H. Meta-analysis of vitamin D, calcium and the prevention of breast cancer. Breast Cancer Res Treat DOI 10.1007/s10549-009-0593-9.
  • 60
    International Agency for research on Cancer. Vitamin D and cancer. IARC Working Group Reports Vol. 5. Lyon: IARC. Available at: www.iarc.fr. Accessed on November 25, 2008.
  • 61
    Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003; 326: 469.
  • 62
    Holick MF. Calcium plus vitamin D and the risk of colorectal cancer. N Engl J Med 2006; 354: 2287–8.
  • 63
    Giovannucci E. Calcium plus vitamin D and the risk of colorectal cancer. N Engl J Med 2006; 354: 2287–8.
  • 64
    Ding EL, Mehta S, Fawzi WW, Giovannucci EL. Interaction of estrogen therapy with calcium and vitamin D supplementation on colorectal cancer risk: reanalysis of Women's Health Initiative randomized trial. Int J Cancer 2008; 122: 1690–4.
    Direct Link:
  • 65
    Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007; 85: 1586–91.
  • 66
    Sood MM, Sood AR. Dietary vitamin D and decreases in cancer rates: Canada as the national experiment. Am J Clin Nutr 2007; 86: 1549–50.
  • 67
    Ojha RP, Felini MJ, Fischbach LA. Vitamin D for cancer prevention: valid assertion or premature anointment?. Am J Clin Nutr 2007; 86: 1804–5.
  • 68
    Bolland MJ, Reid IR. Calcium supplementation and cancer incidence. Am J Clin Nutr 2008; 87: 792–3.
  • 69
    Schabas R. Artifact in the control group undermines the conclusions of a vitamin D and cancer study. Am J Clin Nutr 2008; 87: 792–4.
  • 70
    Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006; 84: 18–28. [Erratum: Am J Clin Nutr 2006; 84: 1253.]
  • 71
    Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266–81.
View Full Article (HTML) Get PDF (331K)